HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

aleglitazar

a dual peroxisome PPAR-alpha and PPAR-gamma agonist for type 2 diabetes
Networked: 21 relevant articles (5 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lincoff, A Michael: 5 articles (04/2014 - 07/2009)
2. Malmberg, Klas: 4 articles (07/2015 - 09/2013)
3. Schwartz, Gregory G: 3 articles (07/2015 - 09/2013)
4. Wedel, Hans: 3 articles (07/2015 - 09/2013)
5. Rydén, Lars: 3 articles (11/2014 - 09/2013)
6. Henry, Robert R: 3 articles (04/2014 - 07/2009)
7. Herz, Matthias: 3 articles (01/2014 - 07/2009)
8. Svensson, Anders: 2 articles (07/2015 - 04/2014)
9. Ruilope, Luis: 2 articles (07/2015 - 01/2014)
10. Volz, Dietmar: 2 articles (07/2015 - 04/2014)

Related Diseases

1. Acute Coronary Syndrome
2. Insulin Resistance
3. Inflammation
4. Heart Failure
5. Weight Gain

Related Drugs and Biologics

1. Peroxisome Proliferator-Activated Receptors (PPAR)
2. Glucose (Dextrose)
3. LDL Cholesterol
4. HDL Cholesterol
5. Apolipoproteins E (ApoE)
6. PPAR alpha
7. Triglycerides (Triacylglycerol)
8. pioglitazone (Actos)
9. Interleukin 1 Receptor Antagonist Protein (Anakinra)
10. Sirolimus (Rapamycin)

Related Therapies and Procedures

1. Stents